University of Chicago: Breast Neoplasms trials

The registry lists 25 Breast Neoplasms studies with University of Chicago as lead sponsor. 3 are open to participants now and 7 have results posted.

Early Phase 1 1Phase 1 4Phase 2 7No phase 13(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Study to Understand Relationship Between Gut Health and Toxicities of Hormonal Breast Cancer TreatmentRecruitingNCT07553234Not applicable
• Assessing the Efficacy and Safety of Anti-HER2 Therapy in Nigerian Women With HER2+ Breast Cancer Before and After SurgeryRecruitingNCT06348134Phase 2
• A Multi-Modality Surveillance Program for Women at High Risk for Breast CancerRecruitingNCT03729115Not applicable
• Accurate, Rapid and Inexpensive MRI Protocol for Breast Cancer ScreeningTerminatedNCT04877912Results posted
• Assessing the Response Rate of Neo-adjuvant Taxotere and Trastuzumab in Nigerian Women With Breast CancerActive, not recruitingNCT03879577Phase 2Results posted
• Abraxane® With or Without Mifepristone for Advanced, Glucocorticoid Receptor-Positive, Triple-Negative Breast CancerActive, not recruitingNCT02788981Phase 2Results posted
• Role of Positron Emission Mammography (PEM) Flex Solo II Positron Emission Tomography (PET) Scanner in Evaluating Neoadjuvant Chemotherapy Response in Patients With Breast CancerTerminatedNCT01012440Not applicableResults posted
• Staging of Axillary Lymph Nodes Using the PEM Flex Solo II Pet Scanner in Patients With Breast CancerCompletedNCT01011946Not applicableResults posted
• Phase II Study of Carboplatin and Bevacizumab (Avastin) for ER Neg, PR Neg, and HER2/Neu Neg Metastatic Breast CancerTerminatedNCT00517361Phase 2Results posted
• Capecitabine as NeoAdjuvant Therapy in Locally Advanced Breast CancerTerminatedNCT00347438Phase 2Results posted
• Autologous Fat Grafting in Radiated Soft Tissue ReconstructionCompletedNCT05890196
• The PhOCus Trial: Implementation of Pharmacogenomic Testing in Oncology CareSuspendedNCT04541381Not applicable
• Abbreviated MRI Protocol: Initial Experience With Dotarem® (Gadoterate Meglumine)CompletedNCT04341129Early Phase 1
• Nature Sounds as a Pain and Anxiety Reducing Strategy in Patients Undergoing Breast Core BiopsyActive, not recruitingNCT03238976Not applicable
• Study of Pembrolizumab and Mifepristone in Patients With Advanced HER2-negative Breast CancerTerminatedNCT03225547Phase 2
• Assessing the Response Rate of Neo-adjuvant Paclitaxel (Taxol) in Nigerian Women With Breast CancerWithdrawnNCT03058939Phase 2
• A Pilot Preoperative Trial of Ganetespib With Paclitaxel for Triple-Negative Breast CancerWithdrawnNCT02637375Not applicable
• A Pharmacodynamic Study of Sirolimus and Metformin in Patients With Advanced Solid TumorsCompletedNCT02145559Phase 1
• Carboplatin, Gemcitabine Hydrochloride, and Mifepristone in Treating Patients With Advanced Breast Cancer or Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal CancerCompletedNCT02046421Phase 1
• Magnetic Resonance Thermal Image Guided Laser Interstitial Thermal Therapy in Treating Patients With Breast CancerWithdrawnNCT01791998Not applicable
• Hypofractionated Image Guided Radiation Therapy in Treating Patients With Stage IV Breast CancerCompletedNCT01706432
• Nab-paclitaxel (Abraxane) With or Without Mifepristone in Patients With Advanced Breast CancerCompletedNCT01493310Phase 1
• A Multi Modality Surveillance Program for Women At High Risk for Breast CancerActive, not recruitingNCT00989638
• Investigation of Genetic Determinants of Capecitabine ToxicityCompletedNCT00977119
• Concomitant Chemoradiotherapy With Weekly Paclitaxel and Vinorelbine and Granulocyte Colony Stimulating Factor (GCSF) Support in Patients With Advanced Breast CancerCompletedNCT00724386Phase 1